BioBusiness Seminar Diabetes

Organised by Van Leeuwenhoeck Research and Hyphen Projects

On October 27th 2010 the third edition of BioBusiness Seminars will be held in Leiden. The BioBusiness Seminars are an initiative of Van Leeuwenhoeck Research and Hyphen Projects. The Seminars will provide an excellent platform for young and promising European life sciences companies to present themselves to potential investors and big pharmaceutical companies. The format of the Seminars will accommodate personal meetings between investors and the presenting companies.

The theme of the third edition is Diabetes. Several of the most promising European biotech companies that are active in the field of Diabetes will present themselves on this day. The following speakers have already confirmed to give a presentation:

· Addex Pharma (Switzerland) – Tim Dyer (CFO) or Charlotte Keywood (CSO)

· Arisgen (Switzerland) – Paolo Botti, Co-founder & Chief Scientific Officer

· Genfit (France) – Dean Hum, Executive Vice President & Chief Scientific Officer

· Proxima Concepts (UK) – Roger New, Co-founder & Research Director

· OctoPlus (Netherlands) – Simon Sturge, CEO

· GW Pharma (UK) – speaker to be announced

· Diabetes Research Foundation (Netherlands) - speaker to be announced

There is room for 60-80 delegates. If you are interested in meeting the above mentioned companies personally, then you are welcome to attend BioBusiness Seminar Diabetes on October 27th 2010 in Leiden, the Netherlands.

Click here to register online for the BioBusiness Seminar Diabetes.
Or click here to download the participant guide and registration form.

An initiative of:

Partners:

Silver Sponsor: